Cera™ ASD Occluder Post-Market Clinical Follow-Up Study
NCT06849635 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 139
Last updated 2025-03-06
Summary
The objective of this post-market study is to:
* collect real-word clinical data and confirm the long-time safety and performance of the Lifetech Cera™ ASD Occluder
* identify previously unknown side-effects
Conditions
- Atrial Septal Defect
Sponsors & Collaborators
-
Lifetech Scientific (Shenzhen) Co., Ltd.
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-03
- Primary Completion
- 2025-12-31
- Completion
- 2026-02-28
Countries
- Poland
Study Locations
More Related Trials
-
Early Feasibility Study for the Foldax Tria Aortic Heart Valve
NCT03851068 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessment of Myocardial Fibrosis in Aortic STenosis
NCT02316587 ·Status: COMPLETED
-
CoreValve Advance International Post Market Study
NCT01074658 ·Status: COMPLETED
-
A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure
NCT03941691 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Coronary Artery Disease Before Transcatheter Aortic Valve Replacement: A Randomized, Multicenter, Non-Inferiority Trial
NCT07107568 ·Status: RECRUITING ·Phase: NA
-
Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis
NCT04333875 ·Status: COMPLETED
-
Comparison of Devices for Atrial Septal Defects Closure: A Pilot Study
NCT04291898 ·Status: UNKNOWN ·Phase: NA
-
To Evaluate Safety and Effectiveness of Transcatheter Aortic Valve System in Patients With Severe Aortic Insufficiency
NCT05424653 ·Status: UNKNOWN ·Phase: NA
-
Surgical Treatment of Aortic Stenosis With a Next Generation, Rapid Deployment Surgical Aortic Valve
NCT01700439 ·Status: COMPLETED ·Phase: NA
-
CoreValve Advance-II Study: Prospective International Post-market Study
NCT01624870 ·Status: COMPLETED
-
Pilot Trial: Comparison of Flow Patterns
NCT02288871 ·Status: UNKNOWN ·Phase: NA
-
Retrospective Clinical Data Collection on Carbomedics OptiForm Mitral Heart Valve
NCT05898230 ·Status: RECRUITING
-
Post Market Registry of the CBSO
NCT04105595 ·Status: UNKNOWN
-
Bioabsorbable Occluder for Outlet VSD: Safety and Aortic Valve Effects
NCT07040579 ·Status: NOT_YET_RECRUITING
-
Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve
NCT01445171 ·Status: COMPLETED ·Phase: NA
-
Role of Aortic Valve Composition in Pathophysiology and Diagnosis of Aortic Stenosis
NCT06136689 ·Status: RECRUITING
-
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
NCT02353351 ·Status: TERMINATED
-
Clinical Evaluation of MDT-2111 in Subjects With Small Aortic Annuli and Symptomatic Severe Aortic Stenosis
NCT01634269 ·Status: COMPLETED ·Phase: NA
-
Behavior of Valve Leaflets Following Aortic Valve Implant
NCT03200574 ·Status: COMPLETED ·Phase: NA
-
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
NCT01092442 ·Status: COMPLETED
-
CryoValve® SG Aortic Human Heart Valve Combination Study
NCT01236469 ·Status: COMPLETED
-
A Comparison of Transcatheter Heart Valves in High Risk Patients With Severe Aortic Stenosis: The CHOICE Trial
NCT01645202 ·Status: COMPLETED ·Phase: NA
-
CLaret Embolic Protection ANd TAVI - Trial
NCT01833052 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve
NCT02434263 ·Status: UNKNOWN ·Phase: NA
-
A Prospective, Multicenter, Observational Study of the Safety and Efficacy of Emergency Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis
NCT07108478 ·Status: NOT_YET_RECRUITING